Ambit Claim: Definition and additional resources from BNET
On GameSpot: Wii Fit tells 10-year-old she's fat

BNET Business Dictionary

Business Definition for: Ambit Claim

  • a claim made to an arbitration authority for higher pay or improved conditions that is deliberately exaggerated because the claimants know that they will subsequently have to compromise

Wiktionary Definition for: Ambit Claim

  • an extravagant initial demand made in expectation of an eventual counter-offer and compromise

Additional Resources

Busy Ambit: new product; IBM deal; $4M In orders - Ambit Design Systems introduces BuildGates - Product Announcement
Santa Clara, Calif.--Ambit Design Systems introduced a new product, entered a development agreement with IBM and announced several purchase commitments.
Tags: IBM Corp.
Research articles 1997-04-21
Cadence's Ambit Gambit - Cadence DesignSystems to acquire Ambit Design Systems - Company Business and Marketing
Plan to strengthen SOC tool arsenal
Tags: Cadence Design Systems Inc., marketing
Research articles 1998-09-07
Ambit and Roche Announce Collaboration and Venture Financing
SAN DIEGO & BASEL, Switzerland -- Roche and Ambit Biosciences today announced a multi-year collaboration, alongside a new equity financing round for Ambit, led by Roche. Under the collaboration, Roche will use Ambit's proprietary kinase screening platform to profile and select small-molecule kinase inhibitors. Ambit will receive milestone payments and...
Tags: collaboration, financing, Roche Holding AG
Research articles 2004-08-26
Cadence To Acquire Ambit? - Cadence Design Systems considers acquisition of Ambit Design Systems - Company Business and Marketing
Rumors have been swirling furiously in the EDA industry that Cadence Design Systems is getting ready to acquire Ambit Design Systems for $250 million. Ambit has been selling its BuildGates logic synthesis tool for over a year and a half, directly competing with Synopsys' Design Compiler -- which propelled the...
Tags: acquisition, Cadence Design Systems Inc., marketing
Research articles 1998-08-24
Ambit Biosciences Announces Compound Profiling Collaboration with Pfizer
SAN DIEGO -- Ambit Biosciences today announced that it has entered into an expanded compound profiling collaboration with Pfizer's La Jolla laboratories. Under the collaboration, Ambit will employ its proprietary "Reverse Screening" technology to identify and characterize the protein targets of certain Pfizer drug discovery compounds and thereby elucidate their...
Tags: collaboration, Pfizer Inc.
Research articles 2005-01-17
Ambit Biosciences Announces Second Expansion of Collaboration with Bristol-Myers Squibb
SAN DIEGO -- Ambit Biosciences today announced a second expansion of its collaboration with Bristol-Myers Squibb Company (NYSE:BMY) for the discovery and development of novel kinase inhibitors. As part of this expansion, Ambit will screen Bristol-Myers Squibb's kinase-focused library using Ambit's proprietary KinomeScan[TM] technology.
Tags: Bristol-Myers Squibb Co., collaboration
Research articles 2007-10-31
Ambit Design Systems - announces that Samsung will add library support for its synthesis tool - Product Information
Ambit Design Systems announced last week that Samsung Electronics Co. Ltd. will add library support for Ambit's ASIC synthesis tool, BuildGates in its MDL110 0.25-micron CMOS technology. Samsung's 0.25-micron technology has been developed for advanced, system-on-a-chip silicon integration with up to 64Mb on-chip DRAM. Target delivery of Ambit libraries to...
Tags: product information, Samsung Electronics Co. Ltd.
Research articles 1998-07-06
Cadence To Acquire Ambit?
Rumors have been swirling furiously in the EDA industry that Cadence Design Systems is getting ready to acquire Ambit Design Systems for $250 million. Ambit has been selling its BuildGates logic synthesis tool for over a year and a half, directly competing with Synopsys' Design Compiler -- which propelled the...
Tags: Cadence Design Systems Inc.
Research articles 1998-08-24
Ambit Biosciences Announces Drug Screening Collaboration with GlaxoSmithKline
SAN DIEGO -- Ambit Biosciences today announced that it has entered into an expanded kinase screening collaboration with GlaxoSmithKline GSK. Under the collaboration, Ambit will employ its proprietary kinase platform to profile kinase target specificity of selected GSK compounds, thereby accelerating the discovery and development of novel drug candidates. Ambit's...
Tags: GlaxoSmithKline Plc.
Research articles 2005-01-17
Ambit Biosciences Announces Drug Screening Collaboration with Bristol-Myers Squibb
SAN DIEGO -- Ambit Biosciences today announced that it has entered into a kinase screening collaboration with Bristol-Myers Squibb Company (NYSE:BMY). Under the collaboration, Ambit will employ its proprietary kinase platform to characterize the specificity of certain Bristol-Myers Squibb compounds. Ambit's groundbreaking kinase platform is a rapidly expanding panel of...
Tags: Bristol-Myers Squibb Co.
Research articles 2005-01-17
Ambit Expands Collaboration with Bristol-Myers Squibb Company, In-Licenses Kinase Inhibitor Program Targeting Solid Tumors
SAN DIEGO -- Ambit Biosciences today announced that it has expanded its collaboration with Bristol-Myers Squibb Company (NYSE:BMY) for the discovery of kinase inhibitors. The five-year agreement provides Bristol-Myers Squibb with access to Ambit's proprietary kinase profiling technology, KinomeScan, to accelerate its internal drug discovery and development efforts. As part...
Tags: Bristol-Myers Squibb Co., collaboration
Research articles 2005-12-12
Synopsys aims secrets charge at Ambit - accuses Ambit Design Systems of misappropriation of trade secrets and other offenses related to the company's hiring of former Synopsys employee Prakash Bhalerao - Company Business and Marketing
Santa Clara, Calif.--Synopsys filed a complaint against Prakash Bhalerao and Ambit Design Systems last month in Santa Clara County Superior Court. The complaint alleges misappropriation of trade secrets; breach of contract; extortion/unfair competition; and breach of fiduciary duty. Synopsys claimed damages of more than $500,000.
Tags: hiring, marketing
Research articles 1997-03-24
Panasonic Adds Ambit Synthesis Tools to 0.25 Micron Technology Offering
SANTA CLARA, Calif.--BUSINESS WIRE--June 29, 1998--Ambit Design Systems, Inc. today announced that Panasonic will add library support in its MN7F 0.25 micron CMOS technology for Ambit's ASIC synthesis tool, BuildGatesTM.
Tags: Panasonic, tool
Research articles 1998-06-29
Ambit Synthesis Tools to be Added to Samsung 0.25 Micron Technology Offering
SANTA CLARA, Calif.--BUSINESS WIRE--June 29, 1998--Ambit Design Systems, Inc. today announced that Samsung Electronics Co., Ltd. will add library support for Ambit's ASIC synthesis tool, BuildGatestm in its MDL110 0.25-micron CMOS technology.
Tags: Samsung Electronics Co. Ltd., tool
Research articles 1998-06-30
Ambit Synthesis Tools to be Added to Samsung 0.25 Micron Technology Offering
SANTA CLARA, Calif.--BUSINESS WIRE--June 29, 1998--Ambit Design Systems, Inc. today announced that Samsung Electronics Co., Ltd. will add library support for Ambit's ASIC synthesis tool, BuildGatestm in its MDL110 0.25-micron CMOS technology.
Tags: Samsung Electronics Co. Ltd., tool
Research articles 1998-06-29
Ambit Biosciences Announces Discovery and Development Collaboration with Cephalon, Inc. Focused on Kinase Inhibitors
SAN DIEGO -- Ambit Biosciences today announced a screening, discovery and development collaboration with Cephalon, Inc. (Nasdaq:CEPH) aimed at bringing best-in-class kinase inhibitors forward as candidates for clinical research.
Tags: Cephalon Inc., collaboration
Research articles 2006-11-06
Cadence Moves Forward With Ambit Merger; Combination Capitalizes on Critical Technologies for SOC Design Flow
SAN JOSE, Calif.--BUSINESS WIRE--Sept. 30, 1998--Cadence Design Systems, Inc. (NYSE:CDN) announced today the consummation of its merger with Ambit Design Systems, Inc. in a move that immediately results in the first complete front-to-back flow for system-on-a-chip SOC design.
Tags: Cadence Design Systems Inc.
Research articles 1998-10-01
Ambit Partners With Leading ASIC Vendors to Develop Static Timing Signoff; IBM, LSI Logic, Lucent, TI & VLSI Technology to sign off on BuildGates timing results
SANTA CLARA, Calif.--BUSINESS WIRE--July 13, 1998--Ambit Design Systems, Inc. today announced plans to work with IBM Microelectronics (NYSE: IBM), LSI Logic (NYSE:LSI), Lucent Technologies Inc. (NYSE:LU), Texas Instruments Incorporated (NYSE:TXN) and VLSI Technology (NASDAQ:VLSI) to use Ambit's BuildGates* multimillion-gate synthesis tool for static timing signoff. These leading ASIC vendors have...
Tags: IBM Corp., LSI Logic Corp., Lucent Technologies Inc., Texas Instruments Inc.
Research articles 1998-07-13
Bhalerao, Bell Make Cadence Believers - founder Gordon Bell and CEO/Chmn Prakash Bhalerao of Ambit Design Systems, - Company Business and Marketing
san jose, calif. -- In what amounts to a $260 million rubber stamp on the vision of Gordon Bell and the perseverance of Prakash Bhalerao, Cadence agreed to acquire Ambit Design Systems, a privately-held company, for $260 million in cash (see story, page 22).
Tags: Cadence Design Systems Inc., marketing
Research articles 1998-09-07
Fourth Acer Affiliate to Incorporate QSound in Their PCs/QSound Labs Signs Taiwan Based Ambit Microsystems, Inc
CALGARY, ALBERTA--BUSINESS WIRE--Dec. 12, 1996-- QSound (TSE QSL., NASDAQ QSNDF.) Continuing to build on its strong relationship with Acer America, QSound Labs has licensed its QXpanderTM technology to Ambit Microsystems, Inc. a Taiwan based Acer affiliate. The royalty-based licensing agreement will see QSound Labs' stereo enhancement technology...
Tags: Acer Inc.
Research articles 1996-12-12
advertisement
advertisement